Phosphorylation Of Alpha-synuclein - A Balancing Act In Parkinson's Disease

Main Category: Parkinson's Disease
Also Included In: Genetics;  Biology / Biochemistry;  Neurology / Neuroscience
Article Date: 13 Oct 2009 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Both genetic and pathologic data indicate a role for the neuronal protein alpha-synuclein in Parkinson disease. Previous studies have indicated that phosphorylation of alpha-synuclein at amino acid 129 (Ser129) is a key event in alpha-synuclein-mediated nerve cell toxicity. However, Mel Feany and colleagues, at Brigham and Women's Hospital, Boston, have now identified a counterbalancing role in nerve cell protection for phosphorylation of alpha-synuclein amino acid 125 (Tyr125).

In the study, phosphorylation of human alpha-synuclein Tyr125 was detected in Drosophila transgenic for human alpha-synuclein and shown to protect from alpha-synuclein-mediated nerve cell toxicity in a Drosophila model of Parkinson disease. That the two phosphorylated amino acids have opposing roles was indicated by the observation that Tyr125 phosphorylation decreased levels of toxic soluble alpha-synuclein oligomers in the Drosophila brain, whereas Ser129 phosphorylation increased them. More importantly, Tyr125 phosphorylation was found to decrease as both humans and Drosophila aged and was reduced in cortical tissue from patients with synucleinopathy dementia with Lewy bodies, a disease related to Parkinson disease. The authors therefore suggest that changes in the balance between Ser129 and Tyr125 phosphorylation - which promote nerve cell toxicity and protection, respectively - might cause alpha-synuclein-mediated nerve cell toxicity in Parkinson disease and related disorders.

TITLE: Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation
http://www.jci.org/articles/view/39088?key=59af0a7e79b38662c2ee

Source:
Karen Honey
Journal of Clinical Investigation

Article adapted by Medical News Today from original press release.
Visit our parkinson's disease section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Karen Honey. "Phosphorylation Of Alpha-synuclein - A Balancing Act In Parkinson's Disease." Medical News Today. MediLexicon, Intl., 13 Oct. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/167144.php>

APA
Karen Honey. (2009, October 13). "Phosphorylation Of Alpha-synuclein - A Balancing Act In Parkinson's Disease." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/167144.php.

Please note: If no author information is provided, the source is cited instead.


Parkinson's Disease

What is Parkinson's Disease?

Parkinson's disease is a gradually progressive, degenerative neurologic disorder which typically impairs the patient's motor skills, speech, writing, as well as some other functions. Read more...

Most Popular Articles



Follow Our Parkinson's Disease News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Parkinson's Disease Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »